Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease-Reference-Cited by-同舟云学术

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease

Published:2019-02 Issue:2 Volume:4 Page:257-266
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Lawitz Eric,Gane Edward,Cohen Eric,Vierling John,Agarwal Kosh,Hassanein Tarek,Mantry Parvez S.,Pockros Paul J.,Bennett Michael,Kemmer Nyingi,Morelli Giuseppe,Zha Jiuhong,Wang Deli,Shulman Nancy S.,Cohen Daniel E.,Reddy K. Rajender

Funder

AbbVie

Publisher

Elsevier BV

Subject

Nephrology

Reference37 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Blach;Lancet Gastroenterol Hepatol,2017

2. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide;Perz;J Hepatol,2006

3. HCV in patients with end-stage renal disease;Okoh;Am J Gastroenterol,2008

4. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis;Lee;PLoS One,2014

5. Treatment of hepatitis C virus infection in patients with end-stage renal disease;Liu;J Gastroenterol Hepatol,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir in Treating HCV Genotypes 1 and 4 in Patients with Advanced Chronic Kidney Disease;Journal of Pharmacy and Bioallied Sciences;2024-07

2. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

3. Interventions for dialysis patients with hepatitis C virus (HCV) infection;Cochrane Database of Systematic Reviews;2023-04-25

4. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C;World Journal of Gastroenterology;2023-02-14

5. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02